The Cost-Effectiveness of Exenatide Bid Versus Insulin Lispro Tid As Add-On Therapy to Titrated Insulin Glargine in Patients With Type 2 Diabetes – An Analysis From The Swedish Health Care Perspective
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.693
https://www.valueinhealthjournal.com/article/S1098-3015(14)02623-0/fulltext
Section Title :
Disease-Specific Studies
Section Order :
115
First Page :
A344
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02623-0&doi=10.1016/j.jval.2014.08.693